FUTURE ONCOL 润色咨询

Future Oncology

出版年份：2005 年文章数：2434 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：6.0% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1224016, encodeId=8bea1224016f2, content=杂志是免费的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d25d5536743, createdName=NYQ, createdTime=Thu Jun 02 10:46:14 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218448, encodeId=09e5121844885, content=偏重的研究方向：肿瘤生信实验<br>经验分享：兄弟们一周了，还在等分配<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c078098854, createdName=ms8000000212980866, createdTime=Tue May 10 14:30:44 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565301, encodeId=54d356530127, content=2018年12月9日小修返修回去，至今仍未分配编辑(ADM:not assigned,under consideration)，不知是不是圣诞节的缘故，临近毕业等得好焦急！希望好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Tue Jan 08 00:00:00 CST 2019, time=2019-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101672, encodeId=426811016e268, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101671, encodeId=949e11016e16d, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052120, encodeId=5092105212039, content=请问这个杂志接收生信文章嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/09/83addc7ceb17d42903520bb6d5762013.jpg, createdBy=ae9e2480154, createdName=持勤, createdTime=Thu Sep 16 22:17:09 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061247, encodeId=4fcd106124ee0, content=请问外审要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sun Oct 17 16:23:41 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566554, encodeId=be2856655415, content=十二月初小修返回至今未安排编辑，有木有哪位大神也跟我情况差不多的？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/9b45fa2ed118b42c499e36ea9151b864.jpg, createdBy=be3f1990312, createdName=显微虾, createdTime=Fri Feb 08 10:06:00 CST 2019, time=2019-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974339, encodeId=e2d19e43390c, content=这个杂志现在很慢了吗？一审45天，大修提交也已经40多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Thu Jun 17 10:58:23 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015383, encodeId=00aa1015383a1, content=偏重的研究方向：肿瘤;癌症<br>经验分享：请问这个期刊接受SEER文章吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210907/1a7ac9a502c14bdba815b201f7d792bd/b6d078994cc44636b8606f737e3795ec.jpg, createdBy=1fe85198778, createdName=qqqqqq@123, createdTime=Tue Sep 07 15:30:31 CST 2021, time=2021-09-07, status=1, ipAttribution=)]
    2022-06-02 NYQ

    杂志是免费的吗

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1224016, encodeId=8bea1224016f2, content=杂志是免费的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d25d5536743, createdName=NYQ, createdTime=Thu Jun 02 10:46:14 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218448, encodeId=09e5121844885, content=偏重的研究方向：肿瘤生信实验<br>经验分享：兄弟们一周了，还在等分配<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c078098854, createdName=ms8000000212980866, createdTime=Tue May 10 14:30:44 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565301, encodeId=54d356530127, content=2018年12月9日小修返修回去，至今仍未分配编辑(ADM:not assigned,under consideration)，不知是不是圣诞节的缘故，临近毕业等得好焦急！希望好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Tue Jan 08 00:00:00 CST 2019, time=2019-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101672, encodeId=426811016e268, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101671, encodeId=949e11016e16d, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052120, encodeId=5092105212039, content=请问这个杂志接收生信文章嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/09/83addc7ceb17d42903520bb6d5762013.jpg, createdBy=ae9e2480154, createdName=持勤, createdTime=Thu Sep 16 22:17:09 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061247, encodeId=4fcd106124ee0, content=请问外审要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sun Oct 17 16:23:41 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566554, encodeId=be2856655415, content=十二月初小修返回至今未安排编辑，有木有哪位大神也跟我情况差不多的？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/9b45fa2ed118b42c499e36ea9151b864.jpg, createdBy=be3f1990312, createdName=显微虾, createdTime=Fri Feb 08 10:06:00 CST 2019, time=2019-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974339, encodeId=e2d19e43390c, content=这个杂志现在很慢了吗？一审45天，大修提交也已经40多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Thu Jun 17 10:58:23 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015383, encodeId=00aa1015383a1, content=偏重的研究方向：肿瘤;癌症<br>经验分享：请问这个期刊接受SEER文章吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210907/1a7ac9a502c14bdba815b201f7d792bd/b6d078994cc44636b8606f737e3795ec.jpg, createdBy=1fe85198778, createdName=qqqqqq@123, createdTime=Tue Sep 07 15:30:31 CST 2021, time=2021-09-07, status=1, ipAttribution=)]
    2022-05-10 ms8000000212980866

    偏重的研究方向：肿瘤生信实验
    经验分享：兄弟们一周了，还在等分配#期刊论坛#

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1224016, encodeId=8bea1224016f2, content=杂志是免费的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d25d5536743, createdName=NYQ, createdTime=Thu Jun 02 10:46:14 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218448, encodeId=09e5121844885, content=偏重的研究方向：肿瘤生信实验<br>经验分享：兄弟们一周了，还在等分配<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c078098854, createdName=ms8000000212980866, createdTime=Tue May 10 14:30:44 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565301, encodeId=54d356530127, content=2018年12月9日小修返修回去，至今仍未分配编辑(ADM:not assigned,under consideration)，不知是不是圣诞节的缘故，临近毕业等得好焦急！希望好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Tue Jan 08 00:00:00 CST 2019, time=2019-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101672, encodeId=426811016e268, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101671, encodeId=949e11016e16d, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052120, encodeId=5092105212039, content=请问这个杂志接收生信文章嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/09/83addc7ceb17d42903520bb6d5762013.jpg, createdBy=ae9e2480154, createdName=持勤, createdTime=Thu Sep 16 22:17:09 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061247, encodeId=4fcd106124ee0, content=请问外审要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sun Oct 17 16:23:41 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566554, encodeId=be2856655415, content=十二月初小修返回至今未安排编辑，有木有哪位大神也跟我情况差不多的？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/9b45fa2ed118b42c499e36ea9151b864.jpg, createdBy=be3f1990312, createdName=显微虾, createdTime=Fri Feb 08 10:06:00 CST 2019, time=2019-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974339, encodeId=e2d19e43390c, content=这个杂志现在很慢了吗？一审45天，大修提交也已经40多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Thu Jun 17 10:58:23 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015383, encodeId=00aa1015383a1, content=偏重的研究方向：肿瘤;癌症<br>经验分享：请问这个期刊接受SEER文章吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210907/1a7ac9a502c14bdba815b201f7d792bd/b6d078994cc44636b8606f737e3795ec.jpg, createdBy=1fe85198778, createdName=qqqqqq@123, createdTime=Tue Sep 07 15:30:31 CST 2021, time=2021-09-07, status=1, ipAttribution=)]
    2019-01-08 1e235a1cm31(暂无匿称)

    2018年12月9日小修返修回去，至今仍未分配编辑(ADM:not assigned,under consideration)，不知是不是圣诞节的缘故，临近毕业等得好焦急！希望好运！

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1224016, encodeId=8bea1224016f2, content=杂志是免费的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d25d5536743, createdName=NYQ, createdTime=Thu Jun 02 10:46:14 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218448, encodeId=09e5121844885, content=偏重的研究方向：肿瘤生信实验<br>经验分享：兄弟们一周了，还在等分配<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c078098854, createdName=ms8000000212980866, createdTime=Tue May 10 14:30:44 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565301, encodeId=54d356530127, content=2018年12月9日小修返修回去，至今仍未分配编辑(ADM:not assigned,under consideration)，不知是不是圣诞节的缘故，临近毕业等得好焦急！希望好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Tue Jan 08 00:00:00 CST 2019, time=2019-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101672, encodeId=426811016e268, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101671, encodeId=949e11016e16d, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052120, encodeId=5092105212039, content=请问这个杂志接收生信文章嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/09/83addc7ceb17d42903520bb6d5762013.jpg, createdBy=ae9e2480154, createdName=持勤, createdTime=Thu Sep 16 22:17:09 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061247, encodeId=4fcd106124ee0, content=请问外审要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sun Oct 17 16:23:41 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566554, encodeId=be2856655415, content=十二月初小修返回至今未安排编辑，有木有哪位大神也跟我情况差不多的？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/9b45fa2ed118b42c499e36ea9151b864.jpg, createdBy=be3f1990312, createdName=显微虾, createdTime=Fri Feb 08 10:06:00 CST 2019, time=2019-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974339, encodeId=e2d19e43390c, content=这个杂志现在很慢了吗？一审45天，大修提交也已经40多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Thu Jun 17 10:58:23 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015383, encodeId=00aa1015383a1, content=偏重的研究方向：肿瘤;癌症<br>经验分享：请问这个期刊接受SEER文章吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210907/1a7ac9a502c14bdba815b201f7d792bd/b6d078994cc44636b8606f737e3795ec.jpg, createdBy=1fe85198778, createdName=qqqqqq@123, createdTime=Tue Sep 07 15:30:31 CST 2021, time=2021-09-07, status=1, ipAttribution=)]
    2021-12-29 msSSSSSD

    如果文章发表了未提供ORCIDID如何添加？

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1224016, encodeId=8bea1224016f2, content=杂志是免费的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d25d5536743, createdName=NYQ, createdTime=Thu Jun 02 10:46:14 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218448, encodeId=09e5121844885, content=偏重的研究方向：肿瘤生信实验<br>经验分享：兄弟们一周了，还在等分配<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c078098854, createdName=ms8000000212980866, createdTime=Tue May 10 14:30:44 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565301, encodeId=54d356530127, content=2018年12月9日小修返修回去，至今仍未分配编辑(ADM:not assigned,under consideration)，不知是不是圣诞节的缘故，临近毕业等得好焦急！希望好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Tue Jan 08 00:00:00 CST 2019, time=2019-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101672, encodeId=426811016e268, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101671, encodeId=949e11016e16d, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052120, encodeId=5092105212039, content=请问这个杂志接收生信文章嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/09/83addc7ceb17d42903520bb6d5762013.jpg, createdBy=ae9e2480154, createdName=持勤, createdTime=Thu Sep 16 22:17:09 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061247, encodeId=4fcd106124ee0, content=请问外审要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sun Oct 17 16:23:41 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566554, encodeId=be2856655415, content=十二月初小修返回至今未安排编辑，有木有哪位大神也跟我情况差不多的？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/9b45fa2ed118b42c499e36ea9151b864.jpg, createdBy=be3f1990312, createdName=显微虾, createdTime=Fri Feb 08 10:06:00 CST 2019, time=2019-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974339, encodeId=e2d19e43390c, content=这个杂志现在很慢了吗？一审45天，大修提交也已经40多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Thu Jun 17 10:58:23 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015383, encodeId=00aa1015383a1, content=偏重的研究方向：肿瘤;癌症<br>经验分享：请问这个期刊接受SEER文章吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210907/1a7ac9a502c14bdba815b201f7d792bd/b6d078994cc44636b8606f737e3795ec.jpg, createdBy=1fe85198778, createdName=qqqqqq@123, createdTime=Tue Sep 07 15:30:31 CST 2021, time=2021-09-07, status=1, ipAttribution=)]
    2021-12-27 Mia

    如何判断两种药物之间是协同作用还是相加作用？

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1224016, encodeId=8bea1224016f2, content=杂志是免费的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d25d5536743, createdName=NYQ, createdTime=Thu Jun 02 10:46:14 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218448, encodeId=09e5121844885, content=偏重的研究方向：肿瘤生信实验<br>经验分享：兄弟们一周了，还在等分配<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c078098854, createdName=ms8000000212980866, createdTime=Tue May 10 14:30:44 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565301, encodeId=54d356530127, content=2018年12月9日小修返修回去，至今仍未分配编辑(ADM:not assigned,under consideration)，不知是不是圣诞节的缘故，临近毕业等得好焦急！希望好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Tue Jan 08 00:00:00 CST 2019, time=2019-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101672, encodeId=426811016e268, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101671, encodeId=949e11016e16d, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052120, encodeId=5092105212039, content=请问这个杂志接收生信文章嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/09/83addc7ceb17d42903520bb6d5762013.jpg, createdBy=ae9e2480154, createdName=持勤, createdTime=Thu Sep 16 22:17:09 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061247, encodeId=4fcd106124ee0, content=请问外审要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sun Oct 17 16:23:41 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566554, encodeId=be2856655415, content=十二月初小修返回至今未安排编辑，有木有哪位大神也跟我情况差不多的？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/9b45fa2ed118b42c499e36ea9151b864.jpg, createdBy=be3f1990312, createdName=显微虾, createdTime=Fri Feb 08 10:06:00 CST 2019, time=2019-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974339, encodeId=e2d19e43390c, content=这个杂志现在很慢了吗？一审45天，大修提交也已经40多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Thu Jun 17 10:58:23 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015383, encodeId=00aa1015383a1, content=偏重的研究方向：肿瘤;癌症<br>经验分享：请问这个期刊接受SEER文章吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210907/1a7ac9a502c14bdba815b201f7d792bd/b6d078994cc44636b8606f737e3795ec.jpg, createdBy=1fe85198778, createdName=qqqqqq@123, createdTime=Tue Sep 07 15:30:31 CST 2021, time=2021-09-07, status=1, ipAttribution=)]
    2021-09-16 持勤

    请问这个杂志接收生信文章嘛

    4

    展开4条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1224016, encodeId=8bea1224016f2, content=杂志是免费的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d25d5536743, createdName=NYQ, createdTime=Thu Jun 02 10:46:14 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218448, encodeId=09e5121844885, content=偏重的研究方向：肿瘤生信实验<br>经验分享：兄弟们一周了，还在等分配<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c078098854, createdName=ms8000000212980866, createdTime=Tue May 10 14:30:44 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565301, encodeId=54d356530127, content=2018年12月9日小修返修回去，至今仍未分配编辑(ADM:not assigned,under consideration)，不知是不是圣诞节的缘故，临近毕业等得好焦急！希望好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Tue Jan 08 00:00:00 CST 2019, time=2019-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101672, encodeId=426811016e268, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101671, encodeId=949e11016e16d, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052120, encodeId=5092105212039, content=请问这个杂志接收生信文章嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/09/83addc7ceb17d42903520bb6d5762013.jpg, createdBy=ae9e2480154, createdName=持勤, createdTime=Thu Sep 16 22:17:09 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061247, encodeId=4fcd106124ee0, content=请问外审要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sun Oct 17 16:23:41 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566554, encodeId=be2856655415, content=十二月初小修返回至今未安排编辑，有木有哪位大神也跟我情况差不多的？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/9b45fa2ed118b42c499e36ea9151b864.jpg, createdBy=be3f1990312, createdName=显微虾, createdTime=Fri Feb 08 10:06:00 CST 2019, time=2019-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974339, encodeId=e2d19e43390c, content=这个杂志现在很慢了吗？一审45天，大修提交也已经40多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Thu Jun 17 10:58:23 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015383, encodeId=00aa1015383a1, content=偏重的研究方向：肿瘤;癌症<br>经验分享：请问这个期刊接受SEER文章吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210907/1a7ac9a502c14bdba815b201f7d792bd/b6d078994cc44636b8606f737e3795ec.jpg, createdBy=1fe85198778, createdName=qqqqqq@123, createdTime=Tue Sep 07 15:30:31 CST 2021, time=2021-09-07, status=1, ipAttribution=)]
    2021-10-17 凶巴巴恰北北怪兽

    请问外审要多久呀

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1224016, encodeId=8bea1224016f2, content=杂志是免费的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d25d5536743, createdName=NYQ, createdTime=Thu Jun 02 10:46:14 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218448, encodeId=09e5121844885, content=偏重的研究方向：肿瘤生信实验<br>经验分享：兄弟们一周了，还在等分配<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c078098854, createdName=ms8000000212980866, createdTime=Tue May 10 14:30:44 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565301, encodeId=54d356530127, content=2018年12月9日小修返修回去，至今仍未分配编辑(ADM:not assigned,under consideration)，不知是不是圣诞节的缘故，临近毕业等得好焦急！希望好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Tue Jan 08 00:00:00 CST 2019, time=2019-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101672, encodeId=426811016e268, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101671, encodeId=949e11016e16d, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052120, encodeId=5092105212039, content=请问这个杂志接收生信文章嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/09/83addc7ceb17d42903520bb6d5762013.jpg, createdBy=ae9e2480154, createdName=持勤, createdTime=Thu Sep 16 22:17:09 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061247, encodeId=4fcd106124ee0, content=请问外审要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sun Oct 17 16:23:41 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566554, encodeId=be2856655415, content=十二月初小修返回至今未安排编辑，有木有哪位大神也跟我情况差不多的？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/9b45fa2ed118b42c499e36ea9151b864.jpg, createdBy=be3f1990312, createdName=显微虾, createdTime=Fri Feb 08 10:06:00 CST 2019, time=2019-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974339, encodeId=e2d19e43390c, content=这个杂志现在很慢了吗？一审45天，大修提交也已经40多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Thu Jun 17 10:58:23 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015383, encodeId=00aa1015383a1, content=偏重的研究方向：肿瘤;癌症<br>经验分享：请问这个期刊接受SEER文章吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210907/1a7ac9a502c14bdba815b201f7d792bd/b6d078994cc44636b8606f737e3795ec.jpg, createdBy=1fe85198778, createdName=qqqqqq@123, createdTime=Tue Sep 07 15:30:31 CST 2021, time=2021-09-07, status=1, ipAttribution=)]
    2019-02-08 显微虾

    十二月初小修返回至今未安排编辑，有木有哪位大神也跟我情况差不多的？？？

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=1224016, encodeId=8bea1224016f2, content=杂志是免费的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d25d5536743, createdName=NYQ, createdTime=Thu Jun 02 10:46:14 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218448, encodeId=09e5121844885, content=偏重的研究方向：肿瘤生信实验<br>经验分享：兄弟们一周了，还在等分配<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c078098854, createdName=ms8000000212980866, createdTime=Tue May 10 14:30:44 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565301, encodeId=54d356530127, content=2018年12月9日小修返修回去，至今仍未分配编辑(ADM:not assigned,under consideration)，不知是不是圣诞节的缘故，临近毕业等得好焦急！希望好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Tue Jan 08 00:00:00 CST 2019, time=2019-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101672, encodeId=426811016e268, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101671, encodeId=949e11016e16d, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052120, encodeId=5092105212039, content=请问这个杂志接收生信文章嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/09/83addc7ceb17d42903520bb6d5762013.jpg, createdBy=ae9e2480154, createdName=持勤, createdTime=Thu Sep 16 22:17:09 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061247, encodeId=4fcd106124ee0, content=请问外审要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sun Oct 17 16:23:41 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566554, encodeId=be2856655415, content=十二月初小修返回至今未安排编辑，有木有哪位大神也跟我情况差不多的？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/9b45fa2ed118b42c499e36ea9151b864.jpg, createdBy=be3f1990312, createdName=显微虾, createdTime=Fri Feb 08 10:06:00 CST 2019, time=2019-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974339, encodeId=e2d19e43390c, content=这个杂志现在很慢了吗？一审45天，大修提交也已经40多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Thu Jun 17 10:58:23 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015383, encodeId=00aa1015383a1, content=偏重的研究方向：肿瘤;癌症<br>经验分享：请问这个期刊接受SEER文章吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210907/1a7ac9a502c14bdba815b201f7d792bd/b6d078994cc44636b8606f737e3795ec.jpg, createdBy=1fe85198778, createdName=qqqqqq@123, createdTime=Tue Sep 07 15:30:31 CST 2021, time=2021-09-07, status=1, ipAttribution=)]
    2021-06-17 prima

    这个杂志现在很慢了吗？一审45天，大修提交也已经40多天了

    2

    展开2条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=1224016, encodeId=8bea1224016f2, content=杂志是免费的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d25d5536743, createdName=NYQ, createdTime=Thu Jun 02 10:46:14 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218448, encodeId=09e5121844885, content=偏重的研究方向：肿瘤生信实验<br>经验分享：兄弟们一周了，还在等分配<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c078098854, createdName=ms8000000212980866, createdTime=Tue May 10 14:30:44 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565301, encodeId=54d356530127, content=2018年12月9日小修返修回去，至今仍未分配编辑(ADM:not assigned,under consideration)，不知是不是圣诞节的缘故，临近毕业等得好焦急！希望好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Tue Jan 08 00:00:00 CST 2019, time=2019-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101672, encodeId=426811016e268, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101671, encodeId=949e11016e16d, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052120, encodeId=5092105212039, content=请问这个杂志接收生信文章嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/09/83addc7ceb17d42903520bb6d5762013.jpg, createdBy=ae9e2480154, createdName=持勤, createdTime=Thu Sep 16 22:17:09 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061247, encodeId=4fcd106124ee0, content=请问外审要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sun Oct 17 16:23:41 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566554, encodeId=be2856655415, content=十二月初小修返回至今未安排编辑，有木有哪位大神也跟我情况差不多的？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/9b45fa2ed118b42c499e36ea9151b864.jpg, createdBy=be3f1990312, createdName=显微虾, createdTime=Fri Feb 08 10:06:00 CST 2019, time=2019-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974339, encodeId=e2d19e43390c, content=这个杂志现在很慢了吗？一审45天，大修提交也已经40多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Thu Jun 17 10:58:23 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015383, encodeId=00aa1015383a1, content=偏重的研究方向：肿瘤;癌症<br>经验分享：请问这个期刊接受SEER文章吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210907/1a7ac9a502c14bdba815b201f7d792bd/b6d078994cc44636b8606f737e3795ec.jpg, createdBy=1fe85198778, createdName=qqqqqq@123, createdTime=Tue Sep 07 15:30:31 CST 2021, time=2021-09-07, status=1, ipAttribution=)]
    2021-09-07 qqqqqq@123

    偏重的研究方向：肿瘤;癌症
    经验分享：请问这个期刊接受SEER文章吗

    1

    展开1条回复
共165条页码: 3/17页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分